The company will study its vaccine in children, including infants as young as six months and those under 12 in the United States and Canada.
Published: March 16, 2021 at 12:02PM
from NYT Health https://ift.tt/2NlQD0f
The company will study its vaccine in children, including infants as young as six months and those under 12 in the United States and Canada.
Published: March 16, 2021 at 12:02PM
from NYT Health https://ift.tt/2NlQD0f